Comparative assessment of immunogenicity and reactogenicity of three different production lots of SB Biologicals combined diphtheria, tetanus, tricomponent acellular (PT 25 g + FHA 25 g + PRN 8 g) vaccine administered as a booster dose in healthy 15 to 24 month old children, Trial ID 208355%2F118

Comparative assessment of immunogenicity and reactogenicity of three different production lots of SB Biologicals combined diphtheria, tetanus, tricomponent acellular (PT 25 g + FHA 25 g + PRN 8 g) vaccine administered as a booster dose in healthy 15 to 24 month old children, Trial ID 208355%2F118 | GSK